Live Breaking News & Updates on Heqet Therapeutics

Stay updated with breaking news from Heqet therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ethris and Heqet Therapeutics Announce Collaboration to Develop RNA-based Therapeutics for Heart Attack and Heart Failure

Ethris and Heqet Therapeutics Announce Collaboration to Develop RNA-based Therapeutics for Heart Attack and Heart Failure
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Mauro Giacca , Ethri Sna , Philipp Schreppel , Melanie Svalander , Ethris Gmb , Pietro Puglisi , Carsten Rudolph , King College London , Lifesci Communications , Heqet Therapeutics Announce Collaboration , Heart Attack , Heqet Therapeutics , College London , Stabilized Nanoparticle ,

Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q2 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the Altamira Therapeutics First Half 2023 Financial Results and Business Update Conference Call. ....

Covadonga Paneda , Thomas Meyer , Altamira Therapeutics Ltd , Washington University Of Medicine , Exchange Commission , Altamira Therapeutics , Call Transcript September , Altamira Therapeutics First Half , Business Update Conference , Altamira Therapeutic Founder , Chief Executive Officer , Chief Operating , Private Securities Litigation Reform Act , Risk Factors , Chief Operating Officer , Consumed Foods In The , Heqet Therapeutics , Washington University ,

Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results

HAMILTON, BERMUDA, Sept. 12, 2023 Company hosts 1H 2023 Financial Results and Business Update call today at 8 a.m. ET First research collaboration with biopharmaceutical company initiated. ....

United States , City Of , United Kingdom , Thomas Meyer , Covadonga Pa , Maria Grunwald , Delivery Technology , Securities Exchange Commission , Securities Exchange , Osteoarthritis Research Society International World Congress , Altamira Therapeutics Ltd , King College London , Washington University School Of Medicine St , Business Update , Altamira Therapeutics , Heqet Therapeutics , Washington University School , Senior Business , Total Nasal Symptom Score , Pharma Nordic , Financial Guidance , Conference Call , Altamira Therapeutics First Half , Access Code , Consolidated Interim Statement , Six Months Ended June ,

Altamira Therapeutics Announces Collaboration With Heqet Therapeutics On Nanoparticle-Delivered Non-Coding Rnas For Cardiac Regeneration

Altamira Therapeutics Announces Collaboration With Heqet Therapeutics On Nanoparticle-Delivered Non-Coding Rnas For Cardiac Regeneration
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , United States , Samuela Wickline , Mauro Giacca , Company Nasdaq , King College London , American Heart Association , Altamira Therapeutics Ltd , School Of Cardiovascular Medicine Sciences , Heqet Therapeutics , Professor Mauro Giacca , Cardiovascular Medicine , Chief Development Officer , Chief Scientific Adviser , College London , Professor Mauro , Claris Ventures ,

Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration

HAMILTON, BERMUDA , July 05, 2023 Heqet will test nanoparticles based on Altamira’s OligoPhore delivery platform in the regeneration of damaged heart tissue Altamira Therapeutics Ltd. . ....

United States , City Of , United Kingdom , Mauro Giacca , Samuela Wickline , Altamira Therapeutics Ltd , School Of Cardiovascular Medicine Sciences , Securities Exchange , King College London , Securities Exchange Commission , American Heart Association , Company Nasdaq , Heqet Therapeutics , Professor Mauro Giacca , Cardiovascular Medicine , Chief Development Officer , Chief Scientific , College London , Professor Mauro , Claris Ventures , Securities Act , Securities Exchange Act , Annual Report ,